| Literature DB >> 30140313 |
Gordon J Hendry1, Linda Fenocchi1, Jim Woodburn1, Martijn Steultjens1.
Abstract
BACKGROUND: Foot pain is common amongst the general population and impacts negatively on physical function and quality of life. Associations between personal health characteristics, lifestyle/behaviour factors and foot pain have been studied; however, the role of wider determinants of health on foot pain have received relatively little attention. Objectives of this study are i) to describe foot pain and foot health characteristics in an educated population of adults; ii) to explore associations between moderate-to-severe foot pain and a variety of factors including gender, age, medical conditions/co-morbidity/multi-morbidity, key indicators of general health, foot pathologies, and social determinants of health; and iii) to evaluate associations between moderate-to-severe foot pain and foot function, foot health and health-related quality-of-life.Entities:
Keywords: Epidemiology; Foot health; Foot pain; Survey
Mesh:
Year: 2018 PMID: 30140313 PMCID: PMC6098653 DOI: 10.1186/s13047-018-0290-1
Source DB: PubMed Journal: J Foot Ankle Res ISSN: 1757-1146 Impact factor: 2.303
Fig. 1Foot pain map used for self-report of location of foot pain
Demographics
| Women ( | Men ( | Total ( | |
|---|---|---|---|
| Age, median (IQR) a | 42 (31–52) | 42 (32–52) | 42 (31–52) |
| BMI, median (IQR) b | 25.2 (22.7–29.6) | 26.8 (24.0–30.7) | 25.8 (23.0–29.9) |
| Social deprivation (lowest 4 deciles), n (%) c | 111 (30.4) | 57 (33.5) | 169 (31.5) |
| Professional occupation, n (%) | 281 (72.6) | 135 (72.6) | 416 (72.5) |
| Employment d | |||
| Paid/self-employed, n (%) | 253 (63.9) | 137 (72.1) | 391 (66.5) |
| Paid/self-employed, part-time, n (%) | 78 (19.7) | 16 (8.4) | 94 (16.0) |
| Voluntary work, n (%) | 3 (0.8) | 5 (2.6) | 8 (1.4) |
| Looking for work, n (%) | 10 (2.5) | 8 (4.2) | 18 (3.1) |
| Student, n (%) | 5 (1.3) | 8 (4.2) | 13 (2.2) |
| Looking after the home/family, n (%) | 3 (0.8) | 1 (0.5) | 4 (0.7) |
| Wholly retired, n (%) | 32 (8.1) | 12 (6.3) | 44 (7.5) |
| Permanently unable to work, n (%) | 2 (0.5) | 0 | 2 (0.3) |
| Other, n (%) | 9 (2.3) | 1 (0.5) | 10 (1.7) |
| Prefer not to answer, n (%) | 1 (0.3) | 2 (1.1) | 4 (0.7) |
| Current smoker, n (%) e | 19 (4.8) | 13 (6.8) | 32 (5.5) |
| Ethnicity | |||
| White Scottish n (%) | 312 (78.2) | 147 (76.6) | 460 (77.6) |
| White other British, n (%) | 48 (12.0) | 22 (11.5) | 70 (11.8) |
| White Irish, n (%) | 4 (1.0) | 3 (1.6) | 7 (1.2) |
| White Polish, n (%) | 5 (1.3) | 1 (0.5) | 6 (1.0) |
| Any other white ethnic group, n (%) | 9 (2.3) | 6 (3.1) | 15 (2.5) |
| Any multiple ethnic groups, n (%) | 7 (1.8) | 1 (0.5) | 8 (1.3) |
| Pakistani, Pakistani Scottish/British, n (%) | 2 (0.5) | 2 (1.0) | 4 (0.7) |
| Indian, Indian Scottish/British, n (%) | 0 | 4 (2.1) | 6 (1.0) |
| Chinese, Chinese Scottish/British, n (%) | 3 (0.8) | 1 (0.5) | 4 (0.7) |
| Any other Asian ethnic group, n (%) | 2 (0.5) | 0 | 2 (0.3) |
| African, African Scottish/British, n (%) | 1 (0.3) | 3 (1.6) | 4 (0.7) |
| Carribean, Carribean Scottish/British, n (%) | 0 | 1 (0.5) | 1 (0.2) |
| Arab, Arab Scottish/British, n (%) | 1 (0.3) | 1 (0.5) | 2 (0.3) |
| Any other ethnic group, n (%) | 1 (0.3) | 0 | 1 (0.2) |
| Prefer not to say, n (%) | 1 (0.3) | 0 | 2 (0.3) |
aage n (%) overall, female, male missing values: 15 (2.5); 12 (3.1); 3 (1.6)
bBMI n (%) overall, female, male missing values: 47 (7.9); 33 (8.3); 13 (6.8)
cSoc dep n (%) overall, female, male missing values: 56 (9.4); 34 (8.8); 22(11.6)
dEmployment status n (%) overall, female, male missing values: 5 (0.84); 3 (0.78); 2 (1.1)
eSmoking status n (%) overall, female, male missing values: 8 (1.3); 6 (1.6); 2 (1.1)
fincludes 2 cases who preferred not to disclose gender
Foot pain, foot health, HRQoL characteristics and gender associations
| Women ( | Men ( | Total ( | Standardised Beta | |
|---|---|---|---|---|
| Foot pain severity (past week) 100 mm VAS scales | ||||
| Left foot, median (IQR) | 10 (0–45) | 8.5 (0–31.8) | 10.0 (0–38.5) | 0.08 |
| Right foot, median (IQR) | 14 (1–50) | 4 (0–34.8) | 11.0 (0–41.0) | 0.08 |
| Overall, median (IQR) | 20 (3–53) | 13 (0–47.3) | 17.0 (2–52.0) | 0.09* |
| Foot Health: FHSQa | ||||
| Pain, median (IQR) | 72.5 (53.8–84.4) | 81.3 (65.6–87.5) | 78.1 (59.4–84.4) | − 0.19* |
| Function, median (IQR) | 93.8 (81.3–100.0) | 100 (87.5–100.0) | 93.8 (81.3–100.0) | − 0.09* |
| General foot health, median (IQR) | 60.0 (42.5–85.0) | 72.5 (60.0–85.0) | 60.0 (42.5–85.0) | −0.11* |
| Footwear, median (IQR) | 50.0 (25.0–75.0) | 75.0 (41.7–100.0) | 58.3 (33.3–83.3) | −0.24* |
| HRQoL: EQ. 5D-5 L | ||||
| EQ 5D-5 L Indexb, median (IQR) | 0.837 (0.735–0.879) | 0.837 (0.767–1.0) | 0.837 (0.740–1.00) | −0.05 |
| EQ 5D-5 L VASc, median (IQR) | 82 (70–90) | 80 (66–90) | 80 (70–90) | 0.07 |
an female = 376; n male = 181; n total 559
bn female = 350; n male = 168; n total 520
cn female = 342; n male = 163; n total 506
dincludes 2 cases who preferred not to disclose gender
*univariate linear regression female gender association significant at p < 0.05
Fig. 2Bar chart representing the lack of a linear relationship between the presence of moderate-to-severe foot pain and increasing age
Foot pain, foot health, HRQoL associations with age and BMI
| Standardised beta | ||
|---|---|---|
| Foot pain severity (past week) 100 mm VAS scales | ||
| Agea | 0.04 | 0.316 |
| BMIb | 0.20 | < 0.001* |
| FHSQ Pain | ||
| Agec | −0.08 | 0.051 |
| BMId | − 0.22 | < 0.001* |
| FHSQ Function | ||
| Agec | −0.03 | 0.448 |
| BMId | − 0.29 | < 0.001* |
| FHSQ General foot health | ||
| Agec | − 0.13 | 0.002* |
| BMId | − 0.25 | < 0.001* |
| FHSQ Footwear | ||
| Agec | −0.09 | 0.040 * |
| BMId | − 0.17 | < 0.001* |
| EQ 5D-5 L Indexb, median (IQR) | ||
| Agee | − 0.10 | 0.025* |
| BMIf | − 0.29 | < 0.001* |
| EQ 5D-5 L VASc, median (IQR) | ||
| Ageg | 0.09 | 0.034 * |
| BMIh | − 0.26 | < 0.001* |
an = 578
bn = 546
cn = 544
dn = 516
en = 508
fn = 483
gn = 493
hn = 470
*Multiple linear regression significant at p < 0.05
Regional foot pain characteristics and gender associations
| Women ( | Men ( | Total ( | Odds ratio (95% CI) F:M | |
|---|---|---|---|---|
| Moderate-to-severe foot pain, n (%) | 169 (42.4) | 66 (34.4) | 236 (39.8) | 1.40 (0.98–2.01) |
| Foot pain region, n (%) | ||||
| Hindfoot | 47 (11.8) | 26 (13.5) | 74 (12.5) | 0.73 (0.45–1.18) |
| Unilateral | 24 (6.0) | 16 (8.3) | 40 (6.7) | |
| Bilateral | 23 (5.8) | 10 (5.2) | 34 (5.7) | |
| Forefoot | 82 (20.6) | 37 (19.2) | 119 (20.1) | 2.24 (1.41–3.56) * |
| Unilateral | 45 (11.3) | 26 (13.5) | 71 (11.9) | |
| Bilateral | 37 (9.3) | 11 (5.7) | 48 (8.1) | |
| Toes | 89 (22.3) | 34 (18.7) | 123 (20.7) | 1.42 (0.94–2.15) |
| Unilateral | 45 (11.3) | 21 (11.9) | 66 (11.1) | |
| Bilateral | 44 (11.0) | 13 (6.8) | 57 (9.6) | |
| Ball | 102 (25.6) | 43 (22.4) | 146 (24.6) | 1.87 (1.24–2.81) * |
| Unilateral | 41 (10.3) | 10 (5.2) | 51 (8.6) | |
| Bilateral | 61 (15.3) | 33 (17.2) | 95 (16.0) | |
| Arch | 105 (26.3) | 51 (26.6) | 156 (26.3) | 1.09 (0.74–1.56) |
| Unilateral | 40 (10.0) | 23 (12.0) | 63 (10.6) | |
| Bilateral | 65 (16.3) | 28 (14.6) | 93 (15.7) | |
| Heel | 72 (18.1) | 37 (19.3) | 110 (18.5) | 1.58 (1.01–2.47) * |
| Unilateral | 31 (7.8) | 17 (8.9) | 49 (8.3) | |
| Bilateral | 41 (10.3) | 20 (10.4) | 61 (10.3) | |
| Nails | 52 (13) | 18 (9.4) | 71 (12.0) | 1.43 (0.83–2.46) |
| Unilateral | 28 (7.0) | 9 (4.7) | 37 (6.2) | |
| Bilateral | 24 (6.0) | 9 (4.7) | 34 (5.7) | |
aincludes 2 cases who preferred not to disclose gender
*Pearson’s chi square significant at p < 0.05
Foot pathologies and associations with moderate-to-severe foot pain (MSFP)
| Women ( | Men ( | Odds ratio (95% CI) F:M | Total ( | Odds ratio (95% CI) MSFP vs. no MSFP | |
|---|---|---|---|---|---|
| Female gender, n (%) | – | – | – | 399 (67.5) | 1.40 (0.98–2.01)* |
| Foot problems previous 6 months | |||||
| Callous | 183 (45.9) | 68 (35.4) | 1.55 (1.08–2.20)** | 252 (42.5) | 1.18 (0.73–1.89) |
| Corns | 68 (17.0) | 13 (6.8) | 2.83 (1.52–5.26)** | 81 (13.7) | 1.18 (0.73–1.89) |
| Fungal | 58 (14.5) | 46 (24.0) | 0.54 (0.35–0.83)** | 105 (17.5) | 1.03 (0.67–1.59) |
| Verruca | 27 (6.8) | 7 (3.6) | 1.92 (0.82–4.49) | 34 (5.7) | 1.21 (0.60–2.43) |
| Bunions | 72 (18.0) | 3 (1.6) | 13.87 (4.31–44.64)**b | 75 (12.6) | 1.66 (1.02–2.69)** |
| Claw toes | 36 (9.0) | 15 (7.8) | 1.17 (0.62–2.19) | 51 (8.6) | 1.51 (0.85–2.68)* |
| Nails | 128 (32.1) | 58 (30.2) | 1.09 (0.75–1.58) | 187 (31.5) | 1.36 (0.96–1.91)* |
aincludes 2 cases who preferred not to disclose gender
bFisher’s exact test
*significant at p < 0.2
**significant at p < 0.05
Comorbidities, health characteristics and associations with moderate-to-severe foot pain (MSFP)
| Women ( | Men ( | Total ( | Odds ratio (95% CI) MSFP vs. no MSFP | |
|---|---|---|---|---|
| Heart disease | 4 (1.0) | 7 (3.6) | 11 (1.9) | 0.56 (0.15–2.14) |
| Treatment | 4 (1.0) | 5 (2.6) | 9 (1.5) | |
| Limiting | 3 (0.8) | 0 (0.0) | 3 (0.5) | |
| High BP | 36 (9.0) | 22 (11.5) | 58 (9.8) | 1.85 (1.07–3.18) ** |
| Treatment | 32 (8.0) | 17 (8.9) | 49 (8.3) | |
| Limiting | 2 (0.5) | 2 (1.0) | 4 (0.7) | |
| Lung Disease | 12 (3.0) | 4 (2.1) | 16 (2.7) | 0.91 (0.33–2.5) |
| Treatment | 12 (3.0) | 3 (1.6) | 15 (2.5) | |
| Limiting | 7 (1.8) | 2 (1.0) | 9 (1.5) | |
| Diabetes | 8 (2.0) | 13 (6.8) | 21 (3.5) | 0.75 (0.29–1.88 |
| Treatment | 6 (1.5) | 9 (4.7) | 15 (2.5) | |
| Limiting | 0 (0.0) | 1 (0.5) | 1 (0.2) | |
| Ulcer/stomach | 10 (2.5) | 7 (3.6) | 17 (2.9) | 2.21 (0.83–5.89) * |
| Treatment | 10 (2.5) | 5 (2.6) | 15 (2.5) | |
| Limiting | 2 (0.5) | 1 (0.5) | 3 (0.5) | |
| Kidney disease d | 2 (0.5) | 3 (1.6) | 5 (0.8) | 2.29 (0.38–13.78) |
| Treatment | 1 (0.3) | 1 (0.5) | 2 (0.3) | |
| Limiting | 0 (0.0) | 1 (0.5) | 1 (0.2) | |
| Liver disease | 0 (0.0) | 0 (0.0) | 0 (0.0) | – |
| Treatment | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| Limiting | 0 (0.0) | 0 (0.0) | 0 (0.0) | |
| Anaemia/blood | 17 (4.3) | 2 (1.0) | 19 (3.2) | 1.71 (0.69–4.28) |
| Treatment | 14 (3.5) | 2 (1.0) | 16 (2.7) | |
| Limiting | 2 (0.5) | 0 (0.0) | 0 (0.0) | |
| Cancer d | 3 (0.8) | 2 (1.0) | 5 (0.8) | 2.29 (0.38–13.78) |
| Treatment | 3 (0.8) | 1 (0.5) | 4 (0.7) | |
| Limiting | 1 (0.3) | 0 (0.0) | 0 (0.0) | |
| Depression | 50 (12.5) | 17 (8.9) | 67 (11.2) | 1.54 (0.93–2.57) * |
| Treatment | 41 (10.3) | 10 (5.2) | 51 (8.6) | |
| Limiting | 25 (6.3) | 7 (3.6) | 22 (3.7) | |
| Osteoarthritis | 30 (7.5) | 3 (1.6) | 33 (5.6) | 1.88 (0.93–3.81) * |
| Treatment | 14 (3.5) | 1 (0.5) | 15 (2.5) | |
| Limiting | 19 (4.8) | 3 (1.6) | 22 (3.7) | |
| Back pain | 114 (28.6) | 42 (21.9) | 156 (26.3) | 2.04 (1.41–2.95) ** |
| Treatment | 34 (8.5) | 17 (8.9) | 51 (8.6) | |
| Limiting | 43 (10.8) | 14 (7.3) | 57 (9.6) | |
| Rheumatoid arthritis d | 5 (1.3) | 4 (2.1) | 9 (1.5) | 12.49 (1.55–100.54) ** |
| Treatment | 5 (1.3) | 2 (1.0) | 7 (1.2) | |
| Limiting | 1 (0.3) | 3 (1.6) | 4 (0.7) | |
| Hip pain | 61 (15.3) | 9 (4.70) | 70 (11.8) | 2.72 (1.63–4.55) ** |
| Treatment | 17 (4.3) | 3 (1.6) | 20 (3.4) | |
| Limiting | 28 (7.0) | 3 (1.6) | 31 (5.2) | |
| Knee pain | 101 (25.3) | 36 (18.8) | 137 (23.1) | 1.56 (1.06–2.30) ** |
| Treatment | 30 (7.5) | 9 (4.7) | 39 (6.6) | |
| Limiting | 54 (13.5) | 19 (9.9) | 73 (12.3) | |
| Other | 76 (19.0) | 39 (20.3) | 115 (19.4) | 1.50 (0.99–2.27) * |
| Treatment | 38 (9.5) | 18 (9.4) | 56 (9.4) | |
| Limiting | 15 (3.8) | 15 (7.8) | 30 (5.1) | |
| SCQ total, median (IQR) | 1 (0–3) | 1 (0–3) | 1 (0–3) | – |
| ≥ 1 Medical condition | 226 (56.6) | 101 (52.6) | 327 (55.1) | 1.94 (1.38–2.72) ** |
| ≥ 2 Medical conditions (multi-morbidity) | 110 (27.6) | 50 (26.0) | 160 (26.9) | 2.04 (1.42–2.95) ** |
| Overweight a | 193 (52.7) | 122 (63.5) | 316 (56.0) | 2.01 (1.41–2.88) ** |
| Low physical activity b | 45 (11.3) | 18 (9.4) | 64 (12.5) | 0.93 (0.54–1.58) |
| Current smoker | 19 (4.8) | 13 (6.8) | 32 (5.4) | 0.90 (0.43–1.88) |
an = 47 values missing
bn = 82 values missing
cincludes 2 cases who preferred not to disclose gender
dFisher’s exact test conducted where cell frequencies < 5
*significant at p < 0.2
**significant at p < 0.05
Fig. 3Bar chart depicting the increasing prevalence of moderate-to-severe foot pain with increasing BMI
Multivariate logistic regression model for independent associations between independent variables and moderate-to-severe foot pain
| Variable | B | SE | Wald | OR (95% CI) | |
|---|---|---|---|---|---|
| Bunions | 0.63 | 0.28 | 5.25 | 0.022* | 1.88 (1.09–3.21) |
| Back pain | 0.64 | 0.21 | 9.22 | 0.002* | 1.90 (1.26–2.88) |
| RA | 1.74 | 1.11 | 2.44 | 0.118 | 5.67 (0.64–50.02) |
| Hip Pain | 0.68 | 0.31 | 4.96 | 0.026* | 1.97 (1.09–3.59) |
| BMI Overweight | 0.61 | 0.19 | 10.06 | 0.002* | 1.84 (1.26–2.68) |
| Occupation Class | 0.45 | 0.21 | 4.53 | 0.033* | 1.57 (1.04–2.37) |
| Constant | −1.279 | 0.18 | 52.70 | 0.000* | |
| Model performance | χ2, df | ||||
| Hosmer Lemeshow | – | – | 6.46, 6 | 0.373 | – |
N = 530 included in multivariate model
Multivariate linear regression models for associations between moderate-to-severe-foot pain, foot function, foot health and HRQoL
| No MSFP | Yes MSFP | |
|---|---|---|
| FHSQ Foot Function a, median (IQR)* | 100 (93.75–100) | 87.5 (68.75–93.75) |
| FHSQ General Foot Health a, median (IQR)* | 85 (60–85) | 60 (25–72) |
| EQ 5D-5 L Index b, median (IQR)* | 84 (75–90) | 76 (60–87) |
| EQ 5D-5 L VAS c, median (IQR)* | 0.85 (0.768–1.00) | 0.767 (0.697–0.837) |
an = 559
bn = 506
cn = 520
*significance at p < 0.05 adjusted for age, gender and BMI